RESUMO
T cells are critical mediators of antigen-specific immune responses and are common targets for immunotherapy. Biomaterial scaffolds have previously been used to stimulate antigen-presenting cells to elicit antigen-specific immune responses; however, structural and molecular features that directly stimulate and expand naïve, endogenous, tumor-specific T cells in vivo have not been defined. Here, an artificial lymph node (aLN) matrix is created, which consists of an extracellular matrix hydrogel conjugated with peptide-loaded-MHC complex (Signal 1), the co-stimulatory signal anti-CD28 (Signal 2), and a tethered IL-2 (Signal 3), that can bypass challenges faced by other approaches to activate T cells in situ such as vaccines. This dynamic immune-stimulating platform enables direct, in vivo antigen-specific CD8+ T cell stimulation, as well as recruitment and coordination of host immune cells, providing an immuno-stimulatory microenvironment for antigen-specific T cell activation and expansion. Co-injecting the aLN with naïve, wild-type CD8+ T cells results in robust activation and expansion of tumor-targeted T cells that kill target cells and slow tumor growth in several distal tumor models. The aLN platform induces potent in vivo antigen-specific CD8+ T cell stimulation without the need for ex vivo priming or expansion and enables in situ manipulation of antigen-specific responses for immunotherapies.
Assuntos
Linfócitos T CD8-Positivos , Linfonodos , Animais , Linfonodos/imunologia , Linfócitos T CD8-Positivos/imunologia , Camundongos , Ativação Linfocitária , Hidrogéis/química , Imunoterapia/métodos , Matriz Extracelular/metabolismo , Antígenos CD28/imunologia , Antígenos CD28/metabolismo , Humanos , Interleucina-2/metabolismo , Peptídeos/química , Linhagem Celular Tumoral , Camundongos Endogâmicos C57BLRESUMO
Cross-reactive immunity between SARS-CoV-2 and other related coronaviruses has been well-documented, and it may play a role in preventing severe COVID-19. Epidemiological studies early in the pandemic showed a geographical association between high influenza vaccination rates and lower incidence of SARS-CoV-2 infection. We, therefore, analyzed whether exposure to influenza A virus (IAV) antigens could influence the T cell repertoire in response to SARS-CoV-2, indicating a heterologous immune response between these 2 unrelated viruses. Using artificial antigen-presenting cells (aAPCs) combined with real-time reverse-transcription PCR (RT-qPCR), we developed a sensitive assay to quickly screen for antigen-specific T cell responses and detected a significant correlation between responses to SARS-CoV-2 epitopes and IAV dominant epitope (M158-66). Further analysis showed that some COVID-19 convalescent donors exhibited both T cell receptor (TCR) specificity and functional cytokine responses to multiple SARS-CoV-2 epitopes and M158-66. Utilizing an aAPC-based stimulation/expansion assay, we detected cross-reactive T cells with specificity to SARS-CoV-2 and IAV. In addition, TCR sequencing of the cross-reactive and IAV-specific T cells revealed similarities between the TCR repertoires of the two populations. These results indicate that heterologous immunity shaped by our exposure to other unrelated endemic viruses may affect our immune response to novel viruses such as SARS-CoV-2.
Assuntos
COVID-19 , Influenza Humana , Antígenos Virais , Linfócitos T CD8-Positivos , Citocinas , Epitopos , Humanos , Receptores de Antígenos de Linfócitos T , SARS-CoV-2RESUMO
Helper (CD4+) T cells perform direct therapeutic functions and augment responses of cells such as cytotoxic (CD8+) T cells against a wide variety of diseases and pathogens. Nevertheless, inefficient synthetic technologies for expansion of antigen-specific CD4+ T cells hinders consistency and scalability of CD4+ T cell-based therapies, and complicates mechanistic studies. Here we describe a nanoparticle platform for ex vivo CD4+ T cell culture that mimics antigen presenting cells (APC) through display of major histocompatibility class II (MHC II) molecules. When combined with soluble co-stimulation signals, MHC II artificial APCs (aAPCs) expand cognate murine CD4+ T cells, including rare endogenous subsets, to induce potent effector functions in vitro and in vivo. Moreover, MHC II aAPCs provide help signals that enhance antitumor function of aAPC-activated CD8+ T cells in a mouse tumor model. Lastly, human leukocyte antigen class II-based aAPCs expand rare subsets of functional, antigen-specific human CD4+ T cells. Overall, MHC II aAPCs provide a promising approach for harnessing targeted CD4+ T cell responses.
Assuntos
Imunoterapia Adotiva , Nanopartículas , Animais , Células Apresentadoras de Antígenos , Linfócitos T CD4-Positivos , Linfócitos T CD8-Positivos , Antígenos HLA , Humanos , CamundongosRESUMO
Multisystem inflammatory syndrome in children (MIS-C) is a rare but deadly new disease in children that rapidly progresses to hyperinflammation and shock, and can lead to multiple organ failure if unrecognized. It has been found to be temporally associated with the COVID-19 pandemic and is often associated with SARS-CoV-2 exposure in children. In this issue of the JCI, Porritt, Paschold, et al. identify restricted T cell receptor (TCR) ß-chain variable domain (Vß) usage in patients with severe MIS-C, indicating a potential role for SARS-CoV-2 as a superantigen. These findings suggest that a blood test that determines the presence of specific TCRß variable gene (TRBV) segments may identify patients at risk for severe MIS-C.
Assuntos
COVID-19 , Criança , Humanos , Pandemias , SARS-CoV-2 , Superantígenos/genética , Síndrome de Resposta Inflamatória Sistêmica , Linfócitos TRESUMO
Recent studies show gut microbiota modulate antitumor immune responses; one proposed mechanism is cross-reactivity between antigens expressed in commensal bacteria and neoepitopes. We found that T cells targeting an epitope called SVYRYYGL (SVY), expressed in the commensal bacterium Bifidobacterium breve (B. breve), cross-react with a model neoantigen, SIYRYYGL (SIY). Mice lacking B. breve had decreased SVY-reactive T cells compared with B. breve-colonized mice, and the T cell response was transferable by SVY immunization or by cohousing mice without Bifidobacterium with ones colonized with Bifidobacterium. Tumors expressing the model SIY neoantigen also grew faster in mice lacking B. breve compared with Bifidobacterium-colonized animals. B. breve colonization also shaped the SVY-reactive TCR repertoire. Finally, SVY-specific T cells recognized SIY-expressing melanomas in vivo and led to decreased tumor growth and extended survival. Our work demonstrates that commensal bacteria can stimulate antitumor immune responses via cross-reactivity and how bacterial antigens affect the T cell landscape.
Assuntos
Antígenos de Neoplasias/imunologia , Epitopos de Linfócito T/imunologia , Microbioma Gastrointestinal/imunologia , Linfócitos T/imunologia , Animais , Bifidobacterium breve/imunologia , Reações Cruzadas/imunologia , Melanoma Experimental , CamundongosRESUMO
Young leaves and flowers of Siamese neem tree (Azadirachta indica A. Juss. var. siamensis Valeton) are commonly consumed as a bitter tonic vegetable. Active antioxidant components in the flowers are rutin and quercetin flavonoids. The aqueous extracts of young flowers collected from 14 different locations in Thailand were quantitatively analysed using high-performance liquid chromatography for the contents of rutin and quercetin, and were determined for the loss on drying, heavy metals and pesticide residues, microbial contamination, solubility, chromatographic fingerprints and acute toxicity. The extracts contained rutin and quercetin in the ranges from 388 to 1178 mg% dry weight (average 772 mg%), and 1 to 10 mg% dry weight (average 5 mg%), respectively. EC50 of the scavenging activity of all extracts was found in the range of 27-133 µg mL(-1). Loss on drying of the extracts was less than 7% w/w and no sign of toxicity (LD50 > 5 g kg(-1)) was found.